151 related articles for article (PubMed ID: 24010978)
21. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.
Gagermeier JP; Rusinak JD; Lurain NS; Alex CG; Dilling DF; Wigfield CH; Love RB
Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023
[TBL] [Abstract][Full Text] [Related]
22. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
[TBL] [Abstract][Full Text] [Related]
23. Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.
Timpone JG; Yimen M; Cox S; Teran R; Ajluni S; Goldstein D; Fishbein T; Kumar PN; Matsumoto C
Transpl Infect Dis; 2016 Apr; 18(2):202-9. PubMed ID: 26853894
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid.
Cinel G; Pekcan S; Ozçelik U; Alp A; Yalçın E; Doğru Ersöz D; Kiper N
J Clin Pharm Ther; 2014 Aug; 39(4):399-403. PubMed ID: 25040449
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
Bruminhent J; Rotjanapan P; Watcharananan SP
Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
Park SY; Lee SO; Choi SH; Kim YS; Woo JH; Sung H; Kim MN; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
J Clin Microbiol; 2011 Dec; 49(12):4179-84. PubMed ID: 22031700
[TBL] [Abstract][Full Text] [Related]
27. Ganciclovir therapy in cytomegalovirus (CMV) infection in immunocompetent pediatric patients.
Avila-Agüero ML; Paris MM; Alfaro W; Avila-Agüero CR; Faingezicht I
Int J Infect Dis; 2003 Dec; 7(4):278-81. PubMed ID: 14656419
[TBL] [Abstract][Full Text] [Related]
28. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I; Len O; de la Cámara R; Gurguí M; Martino R; Jarque I; Barrenetxea C; Díaz de Heredia C; Batlle M; Rovira M; de la Torre J; Torres A; Aguilar M; Espigado I; Martín-Dávila P; Bou G; Borrell N; Aguado JM; Pahissa A;
Antivir Ther; 2011; 16(7):951-7. PubMed ID: 22024510
[TBL] [Abstract][Full Text] [Related]
29. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.
Rose J; Emery VC; Kumar D; Asberg A; Hartmann A; Jardine AG; Bignamini AA; Humar A; Neumann AU
PLoS Pathog; 2017 Apr; 13(4):e1006299. PubMed ID: 28406982
[TBL] [Abstract][Full Text] [Related]
30. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
[TBL] [Abstract][Full Text] [Related]
31. Antiviral combination therapy for cytomegalovirus infection in high-risk infants.
Vora SB; Brothers AW; Waghmare A; Englund JA
Antivir Ther; 2018; 23(6):505-511. PubMed ID: 29790481
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus encephalitis in immunocompetent infants: A 15-year retrospective study at a single center.
Guo Y; Jiang L
Int J Infect Dis; 2019 May; 82():106-110. PubMed ID: 30844517
[TBL] [Abstract][Full Text] [Related]
33. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV.
Hoang QV; Simon DM; Kumar GN; Oh F; Goldstein DA
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):737-40. PubMed ID: 20094728
[TBL] [Abstract][Full Text] [Related]
34. Early clinical manifestations and laboratory findings before and after treatment of cytomegalovirus infection in kidney transplant patients.
Siddiqui WA; Al Salmi I; Jha A; Pakkyara A; Yasir M; Shaheen FAM
Saudi J Kidney Dis Transpl; 2017; 28(4):774-781. PubMed ID: 28748879
[TBL] [Abstract][Full Text] [Related]
35. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of Ganciclovir Resistance in Cytomegalovirus Strains Obtained from Immunocompromised Patients].
Coşkun A; Gökahmetoğlu S; Özmen P; Çevik Ş; Karakükçü M; Kaynar L; Midilli K; Kuşkucu MA
Mikrobiyol Bul; 2020 Oct; 54(4):619-628. PubMed ID: 33107291
[TBL] [Abstract][Full Text] [Related]
37. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
[TBL] [Abstract][Full Text] [Related]
38. Ganciclovir therapy for congenital cytomegalovirus infection in six infants.
Tanaka-Kitajima N; Sugaya N; Futatani T; Kanegane H; Suzuki C; Oshiro M; Hayakawa M; Futamura M; Morishima T; Kimura H
Pediatr Infect Dis J; 2005 Sep; 24(9):782-5. PubMed ID: 16148844
[TBL] [Abstract][Full Text] [Related]
39. Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients.
Atay D; Erbey F; Akcay A; Dag A; Ozturk G
J Pediatr Hematol Oncol; 2015 Oct; 37(7):543-7. PubMed ID: 26207778
[TBL] [Abstract][Full Text] [Related]
40. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
